IL109872A - Tetrahydrobenz ¬CD¾ indole-6-carboxamides for use in preventing emesis and pharmaceutical compositions comprising same - Google Patents
Tetrahydrobenz ¬CD¾ indole-6-carboxamides for use in preventing emesis and pharmaceutical compositions comprising sameInfo
- Publication number
- IL109872A IL109872A IL10987294A IL10987294A IL109872A IL 109872 A IL109872 A IL 109872A IL 10987294 A IL10987294 A IL 10987294A IL 10987294 A IL10987294 A IL 10987294A IL 109872 A IL109872 A IL 109872A
- Authority
- IL
- Israel
- Prior art keywords
- cd3⁄4
- tetrahydrobenz
- carboxamides
- indole
- pharmaceutical compositions
- Prior art date
Links
- KJLFFCRGGGXQKE-UHFFFAOYSA-N 1h-indole-6-carboxamide Chemical class NC(=O)C1=CC=C2C=CNC2=C1 KJLFFCRGGGXQKE-UHFFFAOYSA-N 0.000 title 1
- 206010047700 Vomiting Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Neurology (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7519893A | 1993-06-10 | 1993-06-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL109872A0 IL109872A0 (en) | 1994-10-07 |
IL109872A true IL109872A (en) | 2000-12-06 |
Family
ID=22124191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10987294A IL109872A (en) | 1993-06-10 | 1994-06-02 | Tetrahydrobenz ¬CD¾ indole-6-carboxamides for use in preventing emesis and pharmaceutical compositions comprising same |
Country Status (17)
Country | Link |
---|---|
US (1) | US5703112A (cs) |
EP (2) | EP0633023A3 (cs) |
JP (1) | JPH0748254A (cs) |
KR (2) | KR100367792B1 (cs) |
CN (2) | CN1072932C (cs) |
AU (1) | AU677317B2 (cs) |
CA (1) | CA2125088A1 (cs) |
CZ (2) | CZ285829B6 (cs) |
HK (1) | HK1043322B (cs) |
HU (1) | HUT71464A (cs) |
IL (1) | IL109872A (cs) |
NO (4) | NO321500B1 (cs) |
NZ (2) | NZ260667A (cs) |
RU (1) | RU2154476C2 (cs) |
TW (1) | TW258660B (cs) |
UA (2) | UA29415C2 (cs) |
ZA (1) | ZA943862B (cs) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6613768B1 (en) | 1999-04-30 | 2003-09-02 | Lilly Icos Llc | Treatment of female arousal disorder |
GB0106446D0 (en) * | 2001-03-15 | 2001-05-02 | Vernalis Res Ltd | Chemical compounds |
US8440715B2 (en) | 2005-06-08 | 2013-05-14 | Sk Biopharmaceuticals Co., Ltd. | Treatment of sleep-wake disorders |
US8552060B2 (en) | 2005-06-22 | 2013-10-08 | Sk Biopharmaceuticals Co., Ltd. | Methods for treatment of sexual dysfunction |
IN2012DN00624A (cs) | 2009-06-22 | 2015-06-12 | Sk Biopharmaceuticals Co Ltd | |
CA2779442A1 (en) | 2009-11-06 | 2011-05-12 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
AU2010316106B2 (en) | 2009-11-06 | 2015-10-22 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating attention-deficit/hyperactivity disorder |
US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
DK2968208T3 (da) | 2013-03-13 | 2022-08-22 | Jazz Pharmaceuticals Ireland Ltd | Behandling af kataplexi |
JP6529495B2 (ja) | 2013-07-18 | 2019-06-12 | ジャズ ファーマスティカルズ インターナショナル スリー リミテッドJazz Pharmaceuticals International Iii Limited | 肥満の治療 |
US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
WO2018222954A1 (en) | 2017-06-02 | 2018-12-06 | Jazz Pharmaceuticals International Iii Limited | Methods and compositions for treating excessive sleepiness |
US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4110339A (en) * | 1977-11-25 | 1978-08-29 | Eli Lilly And Company | 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole |
US4521421A (en) * | 1983-09-26 | 1985-06-04 | Eli Lilly And Company | Treatment of sexual dysfunction |
US4576959A (en) * | 1984-02-06 | 1986-03-18 | Eli Lilly And Company | 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles |
CA1266482A1 (en) * | 1984-05-24 | 1990-03-06 | Carl Kaiser | 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines |
US4745126A (en) * | 1987-03-12 | 1988-05-17 | Eli Lilly And Company | Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides |
US4943428A (en) * | 1987-07-10 | 1990-07-24 | Wright State University | Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents |
DE3809155A1 (de) * | 1988-03-18 | 1989-09-28 | Bayer Ag | 1,3,4,5-tetrahydrobenz-(c,d)-indole |
US5204340A (en) * | 1989-04-11 | 1993-04-20 | Eli Lilly And Company | Tetrahydrobenz(c,d)indole serotonin agonists |
JP3005287B2 (ja) * | 1989-07-13 | 2000-01-31 | ファルマシア・アンド・アップジョン・カンパニー | (1,2n)および(3,2n)―炭素環式―2―アミノテトラリン誘導体 |
US5302612A (en) * | 1990-02-26 | 1994-04-12 | Eli Lilly And Company | 6-substituted-hexahydrobenz[cd]indoles |
IL97308A (en) * | 1990-02-26 | 1996-10-31 | Lilly Co Eli | Xahydrobenz [DC] Induced indoles in position 6, their preparation process and pharmaceutical preparations containing them |
AU639536B2 (en) * | 1990-03-15 | 1993-07-29 | Pharmacia & Upjohn Company | Therapeutically useful heterocyclic indole compounds |
US5258379A (en) * | 1990-05-04 | 1993-11-02 | Eli Lilly And Company | Method of inhibiting gastric acid secretion with n-arylpiperazines |
US5096908A (en) * | 1990-05-04 | 1992-03-17 | Eli Lilly And Company | Method of inhibiting gastric acid secretion |
US5229409A (en) * | 1990-08-15 | 1993-07-20 | Eli Lilly And Company | 6-substituted-tetrahydrobenz[cd]indoles |
US5244912A (en) * | 1991-03-28 | 1993-09-14 | Eli Lilly And Company | 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof |
-
1994
- 1994-06-02 NZ NZ260667A patent/NZ260667A/en unknown
- 1994-06-02 CZ CZ982818A patent/CZ285829B6/cs not_active IP Right Cessation
- 1994-06-02 CZ CZ941354A patent/CZ285762B6/cs not_active IP Right Cessation
- 1994-06-02 IL IL10987294A patent/IL109872A/xx not_active IP Right Cessation
- 1994-06-02 NZ NZ314570A patent/NZ314570A/xx unknown
- 1994-06-02 ZA ZA943862A patent/ZA943862B/xx unknown
- 1994-06-03 CA CA002125088A patent/CA2125088A1/en not_active Abandoned
- 1994-06-04 TW TW083105103A patent/TW258660B/zh active
- 1994-06-06 UA UA94005243A patent/UA29415C2/uk unknown
- 1994-06-07 EP EP94304103A patent/EP0633023A3/en not_active Withdrawn
- 1994-06-07 EP EP01201582A patent/EP1166783A3/en not_active Withdrawn
- 1994-06-08 KR KR1019940012778A patent/KR100367792B1/ko not_active IP Right Cessation
- 1994-06-08 AU AU64607/94A patent/AU677317B2/en not_active Ceased
- 1994-06-09 RU RU94020717/14A patent/RU2154476C2/ru not_active IP Right Cessation
- 1994-06-09 JP JP6127646A patent/JPH0748254A/ja active Pending
- 1994-06-09 NO NO19942143A patent/NO321500B1/no unknown
- 1994-06-09 CN CN94106467A patent/CN1072932C/zh not_active Expired - Fee Related
- 1994-06-09 HU HU9401730A patent/HUT71464A/hu unknown
-
1995
- 1995-11-17 US US08/560,174 patent/US5703112A/en not_active Expired - Fee Related
-
1999
- 1999-03-30 NO NO991551A patent/NO991551D0/no unknown
- 1999-07-14 NO NO993461A patent/NO308693B1/no unknown
-
2000
- 2000-06-27 UA UA2000063803A patent/UA37311C2/uk unknown
- 2000-10-31 CN CNB00132828XA patent/CN1170536C/zh not_active Expired - Fee Related
-
2001
- 2001-11-28 NO NO20015806A patent/NO20015806D0/no unknown
-
2002
- 2002-07-12 HK HK02105194.1A patent/HK1043322B/zh not_active IP Right Cessation
- 2002-08-31 KR KR1020020052257A patent/KR100367791B1/ko not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL111221A0 (en) | N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them | |
IL114622A0 (en) | Heteroaryl-oxazolidinones and pharmaceutical compositions containing them | |
IL122485A0 (en) | Arylsulfonylaminobenzene derivatives and pharmaceutical compositions containg the same | |
GB9525977D0 (en) | Perfluoroelastomeric compositions and methods | |
HU9600813D0 (en) | Azole derivatives and pharmaceutical composition thereof | |
IL110988A0 (en) | 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same | |
ZA9684B (en) | Composition and use | |
ZA9410235B (en) | Slow-release insect-repellent formulations and uses | |
IL109872A (en) | Tetrahydrobenz ¬CD¾ indole-6-carboxamides for use in preventing emesis and pharmaceutical compositions comprising same | |
GB9504040D0 (en) | Arylsulfonamide derivative and pharmaceutical composition containing the same | |
HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
IL140742A0 (en) | Raloxifene and pharmaceutical composition comprising the same | |
SG71754A1 (en) | Copolymer and copolymer composition | |
IL109438A0 (en) | 3-Quinolyl-substituted dihydropyridines, processes for their preparation and their use in pharmaceutical compositions | |
HUP0102086A3 (en) | 8-azabicyclo[3.2.1]octane-3-methanamine derivatives and pharmaceutical compositions containing the same | |
IL111467A0 (en) | Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors | |
IL114161A0 (en) | Amido- quinoxalinediones pharmaceutical compositions containing them and their use | |
IL109436A0 (en) | Quinolyl-dihydropyridine esters, processes for their preparation, and their use in pharmaceutical compositions | |
GB9500538D0 (en) | Pyrimidine derivative and pharmaceutical composition | |
GB9306456D0 (en) | Composition and use | |
IL109439A0 (en) | 2-Amino-4-heteroaryl-1, 4-dihydropyridines, processes for their preparation and their use in pharmaceutical compositions | |
AU8108394A (en) | Pharmaceutical composition and use thereof | |
IL109730A0 (en) | Methods for administering biological agents and microparticle compositions useful in these and other methods | |
GB9408859D0 (en) | Composition and use | |
GB9301251D0 (en) | Pharmaceutical compositions and use therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |